Systemic treatment for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality worldwide. Treatment options for patients with advanced stage HCC remain a great challenge. However, novel agents especially small molecule tyrosine kinase inhibitor and innovative immunotherapy demonstrate new prom...
Guardado en:
Autores principales: | Manushi Aggarwal, Abeer Arain, Zhaohui Jin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dd85b95f2f214bc6854270b02bc26dff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evolving therapies in the treatment of hepatocellular carcinoma
por: Hans Christian Spangenberg, et al.
Publicado: (2008) -
Sorafenib for the treatment of unresectable hepatocellular carcinoma
por: Junji Furuse
Publicado: (2008) -
Construction and Comprehensive Analysis of a Stratification System Based on AGTRAP in Patients with Hepatocellular Carcinoma
por: Li Wang, et al.
Publicado: (2021) -
Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Zhou X, et al.
Publicado: (2012) -
Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma
por: Qin JM, et al.
Publicado: (2012)